Project Grant R21AI183192
Award Date
11/8/24
Completion Date
10/31/26
Dollars Obligated
$216K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA 22908, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), provides $658,273 to the University of Massachusetts Medical School to study how Herpes Simplex Virus 1 (HSV-1) interacts with and regulates the NLRP1 inflammasome pathway in human skin cells. The key goals are to identify the mechanisms by which HSV-1 activates and inhibits the NLRP1 inflammasome, and to...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research on manipulating the DNA damage response and proteome on viral genomes during herpes simplex virus (HSV) infection. The $651,832 award, with a project period from November 2024 to October 2029, will enable researchers at The Children's Hospital of Philadelphia to conduct a multi-modal proteomic...
This $411,499 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 (Allergy and Infectious Diseases Research) aims to establish PARP14 as a novel host restriction factor that represses Herpes Simplex Virus 1 (HSV-1) replication. Through in vitro studies and in vivo mouse models, the research will determine how PARP14 binds to the HSV-1 genome and inhibits virus replication. The findings could lead to a greater understanding of how PARP...
This $236,292 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to isolate and characterize the structure of HSV glycoprotein complexes relevant to virus entry. The 2-year project led by Tufts University School of Medicine aims to use antibodies and non-detergent extraction methods to stabilize and isolate the GD/GH/GL and GH/GL/GB glycoprotein complexes,...
This federal Project Grant award of $3,768,791.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research focused on understanding the mechanisms of herpesvirus nuclear egress. The principal investigator at Tufts University School of Medicine will conduct structural and functional studies on the nuclear egress complex (NEC) across different herpesvirus subfamilies, visualize the nuclear...
This federal Project Grant award from the National Institutes of Health (NIH), under the Trans-NIH Research Support (CFDA 93.310) program, provides $1,367,863 to Emory University to conduct biophysical research on herpesvirus capsid assembly and genome packaging. The goal is to develop new methodologies to monitor these essential viral processes in real-time, which could lead to a more complete understanding of herpesviral replication and the development of improved preventative and...
This Project Grant award of $384,363.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Temple University in Philadelphia, PA. The goal of the research is to study the role of the PELLINO1 (PELI1) protein in regulating antiviral immunity in the skin epidermis, with a focus on herpes simplex virus infections. The researchers will use mouse models and human/mouse cell cultures to define...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $471,159 to the University of California, Irvine (UCI) to conduct research on the role of interferon lambda in alpha herpesvirus neuroinvasion. The research aims to elucidate the mechanisms of axonal responses to interferon lambda and their effects on viral invasion of the nervous system, as well as determine how these...
This Project Grant award of $363,969 from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders will support research to characterize the mechanisms by which thyroid hormone regulates HSV-1 latency and reactivation in neurons. The project aims to use computer-guided mutagenesis to generate chimeric viruses and investigate how thyroid hormone binding and neuronal excitability impact...
This federal Project Grant award of $658,657, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research at the University of Virginia on the biophysical and functional coupling of protein condensates to ordered lipid domains in T-cells. The research aims to reveal the mechanisms by which protein condensates and membrane domains cooperatively regulate T-cell signal transduction and...